220 related articles for article (PubMed ID: 19080258)
1. Loss expression of active fragile sites genes associated with the severity of breast epithelial abnormalities.
Wang TT; Frezza EE; Ma R; Hu SY; Liu CZ; Zhang GY; Wachtel MS; Lü XM; Feng JB; Lü CX
Chin Med J (Engl); 2008 Oct; 121(20):1969-74. PubMed ID: 19080258
[TBL] [Abstract][Full Text] [Related]
2. Concordant loss of fragile gene expression early in breast cancer development.
Guler G; Uner A; Guler N; Han SY; Iliopoulos D; McCue P; Huebner K
Pathol Int; 2005 Aug; 55(8):471-8. PubMed ID: 15998374
[TBL] [Abstract][Full Text] [Related]
3. The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma.
Guler G; Uner A; Guler N; Han SY; Iliopoulos D; Hauck WW; McCue P; Huebner K
Cancer; 2004 Apr; 100(8):1605-14. PubMed ID: 15073846
[TBL] [Abstract][Full Text] [Related]
4. The expression of Fhit protein is related inversely to disease progression in patients with breast carcinoma.
Gatalica Z; Lele SM; Rampy BA; Norris BA
Cancer; 2000 Mar; 88(6):1378-83. PubMed ID: 10717620
[TBL] [Abstract][Full Text] [Related]
5. Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer.
Iliopoulos D; Guler G; Han SY; Johnston D; Druck T; McCorkell KA; Palazzo J; McCue PA; Baffa R; Huebner K
Oncogene; 2005 Feb; 24(9):1625-33. PubMed ID: 15674328
[TBL] [Abstract][Full Text] [Related]
6. A novel approach to simultaneously scan genes at fragile sites.
Willem P; Brown J; Schouten J
BMC Cancer; 2006 Aug; 6():205. PubMed ID: 16895604
[TBL] [Abstract][Full Text] [Related]
7. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF
Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768
[TBL] [Abstract][Full Text] [Related]
9. [Loss of fragile histidine triad expression and metastasis in breast cancer].
Zhao P; Li XY; Chen LZ
Ai Zheng; 2002 Jun; 21(6):668-70. PubMed ID: 12452072
[TBL] [Abstract][Full Text] [Related]
10. Study of FHIT and WWOX expression in mucoepidermoid carcinoma and adenoid cystic carcinoma of salivary gland.
Dincer N; Tezel GG; Sungur A; Himmetoglu C; Huebner K; Güler G
Oral Oncol; 2010 Mar; 46(3):195-9. PubMed ID: 20060354
[TBL] [Abstract][Full Text] [Related]
11. Components of DNA damage checkpoint pathway regulate UV exposure-dependent alterations of gene expression of FHIT and WWOX at chromosome fragile sites.
Ishii H; Mimori K; Inageta T; Murakumo Y; Vecchione A; Mori M; Furukawa Y
Mol Cancer Res; 2005 Mar; 3(3):130-8. PubMed ID: 15798093
[TBL] [Abstract][Full Text] [Related]
12. Common chromosomal fragile sites and cancer: focus on FRA16D.
O'Keefe LV; Richards RI
Cancer Lett; 2006 Jan; 232(1):37-47. PubMed ID: 16242840
[TBL] [Abstract][Full Text] [Related]
13. Loss of FHIT expression in breast cancer is correlated with poor prognostic markers.
Arun B; Kilic G; Yen C; Foster B; Yardley DA; Gaynor R; Ashfaq R
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1681-5. PubMed ID: 16030101
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma.
Yang Q; Yoshimura G; Suzuma T; Tamaki T; Umemura T; Nakamura M; Nakamura Y; Wang X; Mori I; Sakurai T; Kakudo K
Clin Cancer Res; 2001 Dec; 7(12):3869-73. PubMed ID: 11751477
[TBL] [Abstract][Full Text] [Related]
15. The FHIT and PTPRG genes are deleted in benign proliferative breast disease associated with familial breast cancer and cytogenetic rearrangements of chromosome band 3p14.
Panagopoulos I; Pandis N; Thelin S; Petersson C; Mertens F; Borg A; Kristoffersson U; Mitelman F; Aman P
Cancer Res; 1996 Nov; 56(21):4871-5. PubMed ID: 8895736
[TBL] [Abstract][Full Text] [Related]
16. [Expression and significance of hTERT mRNA in breast carcinoma and its relation to p53].
Tang F; Gu DH; Wang H; Zhu TF; Zhu HG; Xu ZD; Hu XQ
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):192-5. PubMed ID: 16875603
[TBL] [Abstract][Full Text] [Related]
17. The Fragile Histidine Triad gene and breast cancer.
Yang Q; Yoshimura G; Sakurai T; Kakudo K
Med Sci Monit; 2002 Jul; 8(7):RA140-4. PubMed ID: 12118213
[TBL] [Abstract][Full Text] [Related]
18. WWOX--the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis.
Płuciennik E; Kusińska R; Potemski P; Kubiak R; Kordek R; Bednarek AK
Eur J Surg Oncol; 2006 Mar; 32(2):153-7. PubMed ID: 16360296
[TBL] [Abstract][Full Text] [Related]
19. Large common fragile site genes and cancer.
Smith DI; McAvoy S; Zhu Y; Perez DS
Semin Cancer Biol; 2007 Feb; 17(1):31-41. PubMed ID: 17140807
[TBL] [Abstract][Full Text] [Related]
20. Expression of WWOX and FHIT is downregulated by exposure to arsenite in human uroepithelial cells.
Huang YC; Hung WC; Chen WT; Yu HS; Chai CY
Toxicol Lett; 2013 Jul; 220(2):118-25. PubMed ID: 23618899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
